Is DraftKings (DKNG) Fully Valued As Student Betting Use Puts It Back In Focus?
Why healthcare students are putting DraftKings stock back in focus
A new report on healthcare student finances has drawn attention to DraftKings (DKNG), as a meaningful share of nursing students now use betting and prediction platforms to help cover tuition costs.
This unexpected link between education funding and gaming platforms has put DraftKings under a different kind of spotlight, raising questions about how its products are used and how that context might shape how you think about the stock.
See our latest analysis for DraftKings.
For investors, that spotlight lands on a stock that has recently lost momentum, with the share price at US$22.83 after a 1 day share price return decline of 4.28% and a year to date share price return decline of 35.98%. The 1 year total shareholder return is down 49.06% and the 5 year total shareholder return is down 54.93%, suggesting sentiment has weakened even as DraftKings continues expanding into new markets like Alberta.
If this kind of news has you thinking about where else growth and risk are playing out, it could be worth checking a curated set of 18 top founder-led companies
Bulls point to DraftKings’ growing footprint and recent profitability, while bears focus on steep share price declines and questions around sustainability. How does the current valuation stack up against the evidence on both sides?
Most Popular Narrative: 8.9% Overvalued
Against the last close at $22.83, the most followed narrative pegs DraftKings fair value at $20.97, so the story being told is slightly more cautious than the market price.
DraftKings itself has explored entering the prediction market space, highlighting that management recognizes the category's potential.
DraftKings' stock has declined significantly recently (-45% 1YR), reducing concerns that the company is priced for hypergrowth.
Want to see what keeps that fair value below the current price? The narrative leans heavily on ambitious earnings growth and margin improvement assumptions, alongside higher discounting of risk.
Result: Fair Value of $20.97 (OVERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, sustained revenue growth assumptions and reliance on maintaining market share in a heavily taxed and competitive industry could challenge the current DraftKings narrative.
Find out about the key risks to this DraftKings narrative.
Another View on DraftKings: Cash Flows Tell a Different Story
The user narrative suggests DraftKings looks 8.9% overvalued at $22.83 based on its fair value estimate of $20.97. Our DCF model points the other way, with a future cash flow value of $97.22. That is a wide gap, so which story do you think fits your own risk tolerance better?
Look into how the SWS DCF model arrives at its fair value.
Next Steps
If the mix of concerns and potential rewards around DraftKings leaves you undecided, it may be useful to review the data now and form your own stance using the 3 key rewards and 3 important warning signs
Looking for more investment ideas beyond DraftKings?
If DraftKings has you rethinking where to put fresh capital, you do not need to stop here. A few targeted stock ideas could sharpen your watchlist and highlight new opportunities.
- Target reliable cash generators by scanning the 47 high quality undervalued stocks, which combines quality fundamentals with prices that sit below their estimated worth.
- Prioritise resilience with the 82 resilient stocks with low risk scores, which focuses on companies showing lower risk scores and more durable business profiles.
- Spot earlier stage potential using the screener containing 20 high quality undiscovered gems, which highlights under the radar stocks with stronger underlying metrics than current attention suggests.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com